RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
26 hedge funds and large institutions have $14.2M invested in Regulus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% less ownership
Funds ownership: 55.97% → 54.97% (-1%)
5% less capital invested
Capital invested by funds: $15M → $14.2M (-$783K)
Holders
26
Holding in Top 10
1
Calls
$458K
Puts
$3K
Top Buyers
| 1 | +$49.3K | |
| 2 | +$21.4K | |
| 3 | +$5.77K | |
| 4 |
Citigroup
New York
|
+$2.72K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.77K |
Top Sellers
| 1 | -$36K | |
| 2 | -$4.62K | |
| 3 | -$163 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$82 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$68 |